CUREVAC N V's ticker is CVAC and the CUSIP is N2451R105. A total of 114 filers reported holding CUREVAC N V in Q1 2022. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,857,318 | -14.0% | 3,200,193 | +31.1% | 0.01% | 0.0% |
| Q2 2023 | $25,427,926 | +20.7% | 2,440,300 | -19.3% | 0.01% | +25.0% |
| Q1 2023 | $21,074,513 | +60.3% | 3,023,603 | +38.7% | 0.00% | +33.3% |
| Q4 2022 | $13,149,440 | +601.7% | 2,180,670 | +817.0% | 0.00% | – |
| Q3 2022 | $1,874,000 | -59.8% | 237,816 | -30.7% | 0.00% | -100.0% |
| Q2 2022 | $4,667,000 | -54.6% | 342,930 | -34.6% | 0.00% | -50.0% |
| Q1 2022 | $10,285,000 | +6.6% | 524,500 | +86.5% | 0.00% | 0.0% |
| Q4 2021 | $9,649,000 | -61.3% | 281,232 | -38.4% | 0.00% | -60.0% |
| Q3 2021 | $24,920,000 | -45.9% | 456,231 | -27.3% | 0.01% | -50.0% |
| Q2 2021 | $46,098,000 | +103.1% | 627,346 | +152.8% | 0.01% | +66.7% |
| Q1 2021 | $22,693,000 | +12.6% | 248,122 | -0.2% | 0.01% | +50.0% |
| Q4 2020 | $20,151,000 | +135.4% | 248,554 | +35.2% | 0.00% | +100.0% |
| Q3 2020 | $8,560,000 | – | 183,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,625,943 | $16,942,326 | 13.48% |
| RA Capital Management | 12,245,955 | $127,602,851 | 2.41% |
| Avidity Partners Management LP | 4,300,000 | $44,806,000 | 1.56% |
| Camber Capital Management LP | 1,462,500 | $15,239 | 0.50% |
| Eversept Partners, LP | 357,342 | $3,723,504 | 0.31% |
| Ghisallo Capital Management LLC | 100,000 | $1,042,000 | 0.12% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 226,134 | $2,356,316 | 0.08% |
| Green Alpha Advisors, LLC | 11,492 | $119,747 | 0.08% |
| Alyeska Investment Group, L.P. | 899,423 | $9,371,988 | 0.07% |
| Virtus ETF Advisers LLC | 10,692 | $111,411 | 0.07% |